I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| adipocyte | 10 studies | 58% ± 20% | |
| endothelial cell | 3 studies | 24% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| adipocyte | 10 studies | 58% ± 20% | |
| endothelial cell | 3 studies | 24% ± 2% |
Insufficient scRNA-seq data for expression of SLC19A3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 1398.20 | 226 / 226 | 86% | 5.35 | 351 / 406 |
| brain | 82% | 340.57 | 2175 / 2642 | 90% | 2.18 | 636 / 705 |
| kidney | 91% | 524.73 | 81 / 89 | 62% | 2.90 | 555 / 901 |
| lung | 99% | 931.26 | 573 / 578 | 42% | 1.71 | 483 / 1155 |
| breast | 97% | 7379.35 | 444 / 459 | 43% | 2.15 | 483 / 1118 |
| intestine | 54% | 336.17 | 524 / 966 | 68% | 4.70 | 358 / 527 |
| ovary | 52% | 134.38 | 93 / 180 | 63% | 2.84 | 270 / 430 |
| pancreas | 39% | 111.55 | 128 / 328 | 75% | 4.81 | 134 / 178 |
| adipose | 100% | 9553.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| stomach | 11% | 82.49 | 40 / 359 | 78% | 7.29 | 222 / 286 |
| skin | 46% | 215.21 | 828 / 1809 | 35% | 1.04 | 165 / 472 |
| bladder | 29% | 116.48 | 6 / 21 | 29% | 1.47 | 148 / 504 |
| esophagus | 11% | 50.18 | 162 / 1445 | 37% | 4.17 | 67 / 183 |
| blood vessel | 38% | 329.99 | 510 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 34% | 0.74 | 27 / 80 |
| uterus | 9% | 22.92 | 16 / 170 | 15% | 0.65 | 70 / 459 |
| adrenal gland | 12% | 59.60 | 32 / 258 | 6% | 0.13 | 14 / 230 |
| heart | 14% | 56.47 | 122 / 861 | 0% | 0 | 0 / 0 |
| prostate | 8% | 27.33 | 20 / 245 | 5% | 0.15 | 27 / 502 |
| thymus | 9% | 41.94 | 56 / 653 | 2% | 0.03 | 10 / 605 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.17 | 4 / 45 |
| muscle | 7% | 21.86 | 58 / 803 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0.85 | 1 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.32 | 3 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042723 | Biological process | thiamine-containing compound metabolic process |
| GO_0009229 | Biological process | thiamine diphosphate biosynthetic process |
| GO_0071934 | Biological process | thiamine transmembrane transport |
| GO_0031923 | Biological process | pyridoxine transport |
| GO_0015888 | Biological process | thiamine transport |
| GO_0055085 | Biological process | transmembrane transport |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0015234 | Molecular function | thiamine transmembrane transporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLC19A3 |
| Protein name | Solute carrier family 19 member 3 Thiamine transporter 2 (ThTr-2) (ThTr2) (Solute carrier family 19 member 3) |
| Synonyms | |
| Description | FUNCTION: Mediates high affinity thiamine uptake, probably via a proton anti-port mechanism . Has no folate transport activity . Mediates H(+)-dependent pyridoxine transport . . FUNCTION: Mediates high affinity thiamine uptake, probably via a proton anti-port mechanism. Has no folate transport activity. . |
| Accessions | B8ZZW1 ENST00000409287.5 A0A2R8Y655 E7EM61 ENST00000431622.6 ENST00000644224.2 A0A2R8Y694 C9J4J5 Q9BZV2 B8ZZ39 A0A2R8YFC5 ENST00000409456.2 ENST00000646591.1 ENST00000647113.1 ENST00000419059.1 ENST00000425817.6 C9IZI1 ENST00000645923.1 ENST00000258403.8 ENST00000645700.1 A0A2R8YHG5 ENST00000456524.6 |
